We have received intimation from Mr. Akash Sethi (Promoter & Managing Director) pursuant to Regulation 29(2) of the SEBI (SAST) Regulations regarding acquisition of 75,150 Equity Shares, ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.9 pts less than Nifty Microcap 250 and 1.8 pts less than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Mr. Akash Sethi, Promoter and Managing Director of Shree Pacetronix Ltd, has acquired 75,150 equity shares (representing 2% of the expanded share capital) through the conversion of warrants previously issued to him under a preferential allotment. The acquisition was completed on March 20, 2026. As a result, his direct equity holding increased to 1,63,116 shares (4.35% of the expanded capital), while his warrant holdings reduced correspondingly from 2,25,450 to 1,50,300. His total combined holding (equity plus warrants) remains unchanged at 8.04% of the diluted share capital. The company's total equity share count rose to 37,49,700 shares following this allotment.
Since this is a conversion of warrants already held by the promoter rather than a fresh market purchase, the promoter's overall economic stake in the company remains the same at 8.04%. The filing is a regulatory disclosure and is unlikely to have a material impact on the share price, though it reflects the promoter converting his preferential allotment warrants into actual equity.